224 related articles for article (PubMed ID: 15699322)
1. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.
Brake T; Lambert PF
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2490-5. PubMed ID: 15699322
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
Brake T; Connor JP; Petereit DG; Lambert PF
Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.
Elson DA; Riley RR; Lacey A; Thordarson G; Talamantes FJ; Arbeit JM
Cancer Res; 2000 Mar; 60(5):1267-75. PubMed ID: 10728686
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice.
Bulut G; Fallen S; Beauchamp EM; Drebing LE; Sun J; Berry DL; Kallakury B; Crum CP; Toretsky JA; Schlegel R; Üren A
PLoS One; 2011; 6(11):e27243. PubMed ID: 22087269
[TBL] [Abstract][Full Text] [Related]
5. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.
Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P
Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435
[TBL] [Abstract][Full Text] [Related]
7. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.
Arbeit JM; Howley PM; Hanahan D
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2930-5. PubMed ID: 8610145
[TBL] [Abstract][Full Text] [Related]
8. Requirement for stromal estrogen receptor alpha in cervical neoplasia.
Chung SH; Shin MK; Korach KS; Lambert PF
Horm Cancer; 2013 Feb; 4(1):50-9. PubMed ID: 23065599
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on synergistic action between estrogen, progesterone and human papillomaviruses in cervical cancer].
Wang JT; Gao ES; Cheng YY; Yan JW; Ding L
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):370-3. PubMed ID: 16053767
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
11. A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis.
He C; Lv X; Huang C; Angeletti PC; Hua G; Dong J; Zhou J; Wang Z; Ma B; Chen X; Lambert PF; Rueda BR; Davis JS; Wang C
Cell Rep; 2019 Mar; 26(10):2636-2650.e5. PubMed ID: 30840887
[TBL] [Abstract][Full Text] [Related]
12. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
Yuan F; Chen DZ; Liu K; Sepkovic DW; Bradlow HL; Auborn K
Anticancer Res; 1999; 19(3A):1673-80. PubMed ID: 10470100
[TBL] [Abstract][Full Text] [Related]
13. [Human papillomavirus and cervical cancer].
Matsumoto K
Nihon Rinsho; 2007 Nov; 65(11):2113-24. PubMed ID: 18018579
[TBL] [Abstract][Full Text] [Related]
14. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.
Riley RR; Duensing S; Brake T; Münger K; Lambert PF; Arbeit JM
Cancer Res; 2003 Aug; 63(16):4862-71. PubMed ID: 12941807
[TBL] [Abstract][Full Text] [Related]
15. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
Talora C; Sgroi DC; Crum CP; Dotto GP
Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
[TBL] [Abstract][Full Text] [Related]
16. The role of human papillomaviruses in oncogenesis.
Mighty KK; Laimins LA
Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297
[TBL] [Abstract][Full Text] [Related]
17. Human papillomaviruses and cervical cancer.
DiMaio D; Liao JB
Adv Virus Res; 2006; 66():125-59. PubMed ID: 16877060
[TBL] [Abstract][Full Text] [Related]
18. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
20. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
